580 related articles for article (PubMed ID: 27108788)
1. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.
Zhao L; Mi Y; Guan H; Xu Y; Mei Y
Eur J Pharmacol; 2016 Jul; 783():33-46. PubMed ID: 27108788
[TBL] [Abstract][Full Text] [Related]
2. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
4. Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-β1 signaling.
Zhang CL; Zhao Q; Liang H; Qiao X; Wang JY; Wu D; Wu LL; Li L
J Mol Cell Cardiol; 2018 Mar; 116():135-144. PubMed ID: 29438665
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
Syed AM; Kundu S; Ram C; Kulhari U; Kumar A; Mugale MN; Mohapatra P; Murty US; Sahu BD
Free Radic Biol Med; 2022 Jun; 186():17-30. PubMed ID: 35513128
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis.
Meng G; Zhu J; Xiao Y; Huang Z; Zhang Y; Tang X; Xie L; Chen Y; Shao Y; Ferro A; Wang R; Moore PK; Ji Y
Oxid Med Cell Longev; 2015; 2015():691070. PubMed ID: 26078813
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
[TBL] [Abstract][Full Text] [Related]
9. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
10. Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway.
Liu X; Gai Y; Liu F; Gao W; Zhang Y; Xu M; Li Z
Cardiovasc Res; 2010 Oct; 88(1):150-8. PubMed ID: 20534773
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
Wong CKS; Falkenham A; Myers T; Légaré JF
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.
Morales MG; Vazquez Y; Acuña MJ; Rivera JC; Simon F; Salas JD; Alvarez Ruf J; Brandan E; Cabello-Verrugio C
Int J Biochem Cell Biol; 2012 Nov; 44(11):1993-2002. PubMed ID: 22964022
[TBL] [Abstract][Full Text] [Related]
13. Chymase induces profibrotic response via transforming growth factor-beta 1/Smad activation in rat cardiac fibroblasts.
Zhao XY; Zhao LY; Zheng QS; Su JL; Guan H; Shang FJ; Niu XL; He YP; Lu XL
Mol Cell Biochem; 2008 Mar; 310(1-2):159-66. PubMed ID: 18057996
[TBL] [Abstract][Full Text] [Related]
14. Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation.
Meng Z; Yu XH; Chen J; Li L; Li S
Acta Pharmacol Sin; 2014 Oct; 35(10):1247-56. PubMed ID: 25132338
[TBL] [Abstract][Full Text] [Related]
15. A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats.
Hermida N; López B; González A; Dotor J; Lasarte JJ; Sarobe P; Borrás-Cuesta F; Díez J
Cardiovasc Res; 2009 Feb; 81(3):601-9. PubMed ID: 19019833
[TBL] [Abstract][Full Text] [Related]
16. IMM-H007 improves heart function via reducing cardiac fibrosis.
Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
[TBL] [Abstract][Full Text] [Related]
17. Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo.
Chen X; Long L; Cheng Y; Chu J; Shen Z; Liu L; Li J; Xie Q; Liu H; Wu M; Chen Y; Peng J; Shen A
Biomed Pharmacother; 2021 May; 137():111318. PubMed ID: 33556875
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.
Hong SK; Choo EH; Ihm SH; Chang K; Seung KB
Metabolism; 2017 Nov; 76():42-55. PubMed ID: 28987239
[TBL] [Abstract][Full Text] [Related]
20. Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.
Zhao M; Zheng S; Yang J; Wu Y; Ren Y; Kong X; Li W; Xuan J
PLoS One; 2015; 10(3):e0121312. PubMed ID: 25793583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
